Protective effects of endothelin receptor A and B inhibitors against doxorubicin-induced cardiomyopathy.
Schwebe M, Ameling S, Hammer E, Monzel JV, Bonitz K, Budde S, Schult K, Oswald S, Scheuch E, Grube M, Poesch A, Budde T, Ewert R, Schroeder HW, Kroemer HK, Bien-Möller S.
Schwebe M, et al. Among authors: poesch a.
Biochem Pharmacol. 2015 Mar 15;94(2):109-29. doi: 10.1016/j.bcp.2015.01.014. Epub 2015 Feb 7.
Biochem Pharmacol. 2015.
PMID: 25660617